Faculty, staff and students at LSU Health Shreveport are actively engaged in research in a variety of biomedical areas, with concentrations in cancer, cardiovascular sciences, virology, neuroscience, addiction  and immunology. A core part of the institution’s mission, research on campus ranges from basic science to translational research and testing the latest therapies in clinical trials. The School of Graduate Studies helps to train future scientists, and our six centers, four of which are Louisiana Board of Regents recognized Centers of Excellence, further elevate our research portfolio.  

The Office of the Vice Chancellor for Research supports these endeavors and is comprised of the Office for Sponsored Programs and Technology Transfer, Research Development and Management, Human Research Protections Program (HRPP), the Institutional Review Board (IRB), and the Research Core Facility.  

  

Research by the NUMBERS

 

TOTAL Federal Grant Funding (FY21-22)

$18,490,000

↑ 300% increase in grant funding since FY15

Technology Transfer (FY20-21)

Invention Disclosures: 32
Patents Filed: 421  l  Patents Issued: 8 U.S. / 1 Foreign
Licenses and Options: 6
Total Licensing Income: $519,000
Ranked 2nd in the LSU System for tech transfer

   

   

 

RECENT RESEARCH AWARDS

Dr. A. Wayne Orr receives grant from the NIH’s National Heart, Lung and Blood Institute

A. Wayne Orr, PhD, Professor and Director of the Research Division for Pathology and Translational Pathobiology, and Center for Cardiovascular Diseases and Sciences Director, received a 5-year $2,87 million R01 grant from the NIH National Heart, Lung, and Blood Institute for his project, "EphA2 regulation of atherosclerotic smooth muscle phenotype." 

Read More about Dr. A. Wayne Orr receives grant from the NIH’s National Heart, Lung and Blood Institute
Dr. Nirav Dhanesha received a 5-year $2.24 million R01 grant from the NIH’s National Heart, Lung and Blood Institute

Nirav Dhanesha, PhD, Assistant Professor of Pathology and Translational Pathobiology, received a 5-year $2.24 million R01 grant from the NIH’s National Heart, Lung and Blood Institute for his project “Mechanisms for Deep Vein Thrombosis following Stroke.”

Read More about Dr. Nirav Dhanesha received a 5-year $2.24 million R01 grant from the NIH’s National Heart, Lung and Blood Institute
LSUHS Center for Redox Biology and Cardiovascular Disease CoBRE awarded a $730,000 supplement award

The Center for Redox Biology and Cardiovascular Disease CoBRE at LSU Health Shreveport, led by Principal Investigator Chris Kevil, PhD, was awarded a $730,000 supplement award from the NIH’s National Institute of General Medical Sciences (NIGMS) for “SARS-CoV-2 Genomic Surveillance in North Louisiana.”

Read More about LSUHS Center for Redox Biology and Cardiovascular Disease CoBRE awarded a $730,000 supplement award

 

LATEST NEWS HIGHLIGHTS

nurse in blue coverings in hospital room

A new study led by researchers at LSU Health Shreveport recently published in JACC: Advances found there has been a drastic increase in cardiomyopathy - associated hospital admissions among methamphetamine users in the United States, as well as significant social and geographic disparities associated with these cases.

Read More about LSUHS Study Finds Significant Increase and Demographic Disparities in Meth Users Hospitalized for Cardiomyopathy

Office of Research

Achieving International Distinction for Our Basic Science and Clinical Research Programs